Quick Takeaways
- JPMORGAN CHASE & CO filed SCHEDULE 13G/A for INSMED INCORPORATED Common stock, par value $0.01 per share (INSM).
- Disclosed ownership: 11%.
- Date of event: 29 Aug 2025.
JPMORGAN CHASE & CO - 29 Aug 2025 SCHEDULE 13G/A Report for INSMED INCORPORATED Common stock, par value $0.01 per share (INSM)
- Filing Manager
- JPMORGAN CHASE & CO
- Reporting Manager
- JPMORGAN CHASE & CO.
- Symbol
- INSM
- Shares outstanding
- 213,098,000 shares
- Disclosed Ownership
- 23,014,584 shares
- Ownership
- 11%
- Form type
- SCHEDULE 13G/A
- Filing time
- 04 Sep 2025, 13:41:37 UTC
- Date of event
- 29 Aug 2025
- Previous filing
- 30 Jul 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"JPMORGAN CHASE & CO disclosed 11% ownership in INSMED INCORPORATED Common stock, par value $0.01 per share (INSM) on 29 Aug 2025."
What Changed
- Previous schedule filing date: 30 Jul 2025.
- Current filing was accepted on 04 Sep 2025, 13:41.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (1)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| JPMORGAN CHASE & CO. | 11% | 23,014,584 | 20,997,990 | 7,895 | Rachel Tsvaygoft | Vice President |